Location History:
- Baltimore, MD (US) (2004)
- South Pasadena, CA (US) (2001 - 2006)
- Livermore, CA (US) (2010)
Company Filing History:
3 out of 1,635 
1 out of 1 Years Active: 2001-2010
Title: Mark L Gonzalgo: Innovator in Cancer Diagnostics
Introduction
Mark L Gonzalgo is a prominent inventor based in Livermore, CA (US). He has made significant contributions to the field of cancer diagnostics, holding a total of 4 patents. His innovative methods focus on utilizing DNA methylation differences to improve cancer detection and diagnosis.
Latest Patents
One of his latest patents is a cancer diagnostic method based upon DNA methylation differences at specific CpG sites. This inventive method involves a bisulfite treatment of DNA, followed by methylation-sensitive single nucleotide primer extension (Ms-SNuPE). This process allows for the determination of strand-specific methylation status at cytosine residues, which is crucial for accurate cancer diagnosis.
Career Highlights
Throughout his career, Mark has worked with esteemed institutions such as the University of Southern California and the USC/Norris Comprehensive Cancer Center. His work in these organizations has furthered research and development in cancer diagnostics, showcasing his commitment to advancing medical science.
Collaborations
Mark has collaborated with notable professionals in his field, including Peter A Jones and Gangning Liang. These partnerships have contributed to the success of his research and the development of his patented methods.
Conclusion
Mark L Gonzalgo is a dedicated inventor whose work in cancer diagnostics has the potential to significantly impact patient care. His innovative approaches and collaborations highlight the importance of research in the fight against cancer.